MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Ciprofibrate

Ciprofibrate 100mg tablets

Compatible

Stability notes for Ciprofibrate 100mg tablets

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Ciprofibrate 100mg tablets (Zentiva Pharma UK Ltd).

Suppliers (9) of Ciprofibrate 100mg tablets
Ciprofibrate 100mg tablets (A A H Pharmaceuticals Ltd)
Ciprofibrate 100mg tablets (Accord-UK Ltd)
Ciprofibrate 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Ciprofibrate 100mg tablets (CST Pharma Ltd)
Ciprofibrate 100mg tablets (Medihealth (Northern) Ltd)
Ciprofibrate 100mg tablets (Necessity Supplies Ltd)
Ciprofibrate 100mg tablets (Phoenix Healthcare Distribution Ltd)
Ciprofibrate 100mg tablets (Sigma Pharmaceuticals Plc)
Ciprofibrate 100mg tablets (Zentiva Pharma UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.